Hiccup Clinical Trial
Official title:
A Feasibility Double-Blinded, Randomized Study of Educational Materials for Hiccups
| NCT number | NCT05313685 |
| Other study ID # | 21-012057 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 6, 2021 |
| Est. completion date | March 25, 2022 |
| Verified date | June 2022 |
| Source | Mayo Clinic |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This is a research study about hiccup educational materials. The purpose of this study is to learn whether this type of research can be done.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | March 25, 2022 |
| Est. primary completion date | February 23, 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Age = 18 years of age. - Hiccups in the 4 weeks prior to phone contact (patient must confirm). - Able to speak and read English. - Has an e-mail address. Exclusion Criteria: - Individuals < 18 years of age. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Mayo Clinic Rochester | Rochester | Minnesota |
| Lead Sponsor | Collaborator |
|---|---|
| Mayo Clinic |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Feasibility of enrollment | This is a feasibility study that seeks to enroll 20 patients with hiccups in 5 months from the start of trial recruitment. | 5 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05749159 -
New Physitherapy or Alternative Therapy for Hiccup
|
N/A | |
| Withdrawn |
NCT01277731 -
Methylprednisolone Replacement for Dexamethasone-induced Hiccup
|
N/A | |
| Not yet recruiting |
NCT03778281 -
Treatment of Chemotherapy-related Hiccups With Baclofen
|
Phase 4 |